Journals / Türk Anestezi ve Reanimasyon Dergisi / 2008 / Cilt: 36 - Sayı: 2

Xeroderma pigmentosum and anesthesia management (Case report)

Kserderma pignemtozum ve anestezi uygulaması

Pages
124–127
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After the functions of respiratory and cardiovascular system parameters were determined to be normal, the patient was transported to the related clinic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Xeroderma Pigmentosum (XP) is a rare, autosomal recessive disease.
📊
Key Findings & Data:Our case was a 22 years old female patient to whom extraction was planned for multiple tumors under general anesthesia.
💡
Conclusion & Impact:After the functions of respiratory and cardiovascular system parameters were determined to be normal, the patient was transported to the related clinic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Xeroderma Pigmentosum (XP) is a rare, autosomal recessive disease. It is seen more frequently in people who have sensitivity to UV rays. Our case was a 22 years old female patient to whom extraction was planned for multiple tumors under general anesthesia. No premedication was applied and intubation was accepted to be difficult because the orifice distance was 3 cm. Propofol 2 mg kg-1, fentanyl 2 µq kg-1 and succinylcholine 1,5 mg kg-1 were used to induce anesthesia and intubation was applied at second trial. Anesthesia maintained, with propofol (3 µg ml-1), remifentanil (6 µg ml-1) by using target control infusion (TCI) with Fresenius Orchestra Base Primea. BIS monitorization was used to determine the sedation level. BIS values were kept in between 40-60 %. The operation lasted about two hours. After the functions of respiratory and cardiovascular system parameters were determined to be normal, the patient was transported to the related clinic.

Özet

Kseroderma Pigmentosum (KP), ender görülen otozomal resesif geçişli bir hastalıktır. Ultraviyole ışınlarına hassas olan kişilerde daha sık olarak görülmektedir. Olgumuz 22 yaşında kadın hasta idi ve multipl bazal ve skuamöz hücreli tümöral oluşumlar nedeniyle genel anestezi altında kitle eksizyonu için ameliyat planlandı. Premedikasyon uygulanmayan hastanın ağız açıklığı 3 cm olduğundan zor entübasyon adayı olarak kabul edildi. İndüksiyonda fentanil 2 µg kg-1, propofol 2 mg kg-1 ve süksinil kolin 1,5 mg kg-1 uygulandı ve ikinci denemede entübasyon gerçekleştirildi. Anestezi idamesi için remifentanil (6 µg ml-1) ve propofol (3 µg ml-1) hedef kontrollü infüzyonla (Fresenius orchestra base primea cihazı) uygulandı. Anestezi derinliği monitorizasyonu için BIS (bispektral indeks) cihazı kullanıldı. Hastanın BIS skoru ameliyat sırasında % 40-60 aralığında tutuldu. Hasta iki saat süren ameliyat sonucunda sorunsuz ekstübe edildi. Derlenme odasına alınan hasta, hemodinamisinin ve solunum fonksiyonlarının stabil olduğu tespit edildikten sonra ilgili servise devredildi

🔖

Cite This Article

ARIKAN, Z., TEMİZEL, F., KUZUCUOĞLU, T., YETER, H. (2022). Xeroderma pigmentosum and anesthesia management (Case report). Türk Anestezi ve Reanimasyon Dergisi, Cilt: 36 - Sayı: 2, 124–127. https://ajindex.com/articles/619977

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Brunner T, Jörhr M. Anesthetic management of a child with xeroderma pigmentosum. Pediatric Anesth 2004; 14:697-98
  2. Moriwaki S, Kraemer KH. Xeroderma pigmentosum- bridging agap between clinic and laboratory. Photodermatol photoimmunol Photomed 2001; 17:47-54
  3. Müftüoğlu Meltem. DNA tamiri ve Erken yaşlanma Sendromları. Türk Biyokimya Dergisi 2003; 28:20-24
  4. Olivera CRD, Elias L, Barros ACDM. Anesthesia in patient with xeroderma pigmentosum. Rev. Bras. Anestesiol 2003; 53:46-51
  5. Meyer RJ. Awake blind nasal intubation in a patient with xeroderma pigmentosum. Anesth Intensive Care 1982; 10:64-66
  6. Ohto T, Iwasaki N, Okubo H, Shin K, Matsui A. Life-threating vocal cord paralysis in a patient with group A xeroderma pigmentosum. Pediatr Neurol 2004; 222-224
  7. Masuda Y, Imaizumi H, Okanuma M, et al. Anesthesia for a patient with xeroderma pigmentosum. Masui 2002; 5:169-171
  8. Reitz M, Lanz E. DNA strand breaks in cells with DNA repair deficiency after halothane exposure in vitro. Arzneimittelforschung 1993; 43:418-420
  9. Miyazaki R, Nagata T, Kaia T, Takahashi S. Anesthesia for a patient with xeroderma pigmentosum. Masui 2007; 56(4):439-4
  10. Soen M, Kagawa T, Uokawa R, Suziki T. Anesthetic management of a patient with xeroderma pigmentosum. Masui 2006; 55:215-217.